AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shankar, S.
Right arrow Articles by Silverman, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shankar, S.
Right arrow Articles by Silverman, S. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2004; 183:1425-1429
© American Roentgen Ray Society

Combined Radiofrequency and Alcohol Injection for Percutaneous Hepatic Tumor Ablation

Sridhar Shankar1,2,3, Eric vanSonnenberg2,3, Paul R. Morrison3, Kemal Tuncali3 and Stuart G. Silverman3

1 Department of Radiology, University of Massachusetts, 55 Lake Ave. N, Worcester, MA 01655.
2 Department of Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115.
3 Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115.

OBJECTIVE. We sought to determine if alcohol potentiates radiofrequency energy by obtaining larger ablative volumes in 30 liver tumors in human patients.

SUBJECTS AND METHODS. We compared two groups of patients: one group treated with radiofrequency ablation alone (radiofrequency-alone group), and a second group treated with radiofrequency ablation and immediate prior injection of alcohol (combined group). The radiofrequency-alone group comprised 20 ablations (mean diameter, 8.4 cm; colorectal cancer metastases [n = 15]; other metastases [n = 5]). The combined group consisted of 30 radiofrequency ablations (mean diameter, 8.8 cm; metastatic colorectal cancer [n = 17]; other metastases [n = 8]; and hepatocellular carcinoma [n = 5]) treated with alcohol injection immediately before radiofrequency ablation. The amount of alcohol injected was determined by the size and location of tumors. Preprocedural laboratory tests (complete blood cell count with differential, liver function tests, and coagulation parameters) were performed in all patients, along with pre- and postprocedural CT, MRI, and PET. Measurements of tissue necrosis were obtained on the postprocedural CT scans and MR images. Volumes of necrosis calculated in each group were corrected for the number of radiofrequency applications and were statistically compared using the Student's t test. In addition, tissue impedances obtained during the radiofrequency ablation procedure were compared between the two groups.

RESULTS. The mean ablation volumes for the radiofrequency-alone group were 32.3 cm2 (median, 28.6 cm2; range, 14.4–61.8 cm2) and for the combined group, 84.6 cm2 (median, 78.3 cm2; range, 34.6–149 cm2). The difference in the necrosis volumes was significantly larger (p < 0.0001) in the combined group. Overall, the combined treatment group underwent fewer radiofrequency applications per session. Tissue impedance during radiofrequency ablation was higher in the combined group (mean, 62.7 vs 57.3 {Omega} in the radiofrequency alone group; p = 0.0005) at comparable times during the ablations. No major complications were seen in either group.

CONCLUSION. Percutaneous radiofrequency ablation appears to be potentiated by immediate prior alcohol injection into the tumor. Consistently larger lesions are obtainable in fewer sessions, without any increase of complications, using the combined method.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
R. T. Nair, E. vanSonnenberg, S. Shankar, P. R. Morrison, R. R. Gill, K. Tuncali, and S. G. Silverman
Visceral and Soft-Tissue Tumors: Radiofrequency and Alcohol Ablation for Pain Relief--Initial Experience
Radiology, September 1, 2008; 248(3): 1067 - 1076.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
O. Catalano, P. Vallone, F. Izzo, and A. Siani
An Inaccurate Literature Review and Citation
Radiology, March 1, 2008; 246(3): 982 - 982.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. N. Wong, C.-J. Lin, C.-C. Lin, W.-T. Chen, I. H. Y. Cua, and S.-M. Lin
Combined Percutaneous Radiofrequency Ablation and Ethanol Injection for Hepatocellular Carcinoma in High-Risk Locations
Am. J. Roentgenol., March 1, 2008; 190(3): W187 - W195.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. Schraml, C. Aube, H. Graf, A. Boss, S. Clasen, T. Herberts, D. Schmidt, F. Schick, C. D. Claussen, and P. L. Pereira
MR-guided Radiofrequency Ablation: Do Magnetic Fields Influence Extent of Coagulation in ex Vivo Bovine Livers?
Radiology, December 1, 2006; 241(3): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Oei, E. vanSonnenberg, S. Shankar, P. R. Morrison, K. Tuncali, and S. G. Silverman
Radiofrequency Ablation of Liver Tumors: A New Cause of Benign Portal Venous Gas
Radiology, November 1, 2005; 237(2): 709 - 717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Roentgen Ray Society.